Behind the Scale-Up: From Cell Bank to Commercial ManufacturingByAndrew Mitchell, Agilent Advanced TherapeuticsSeptember 2nd 2026Sponsored
Making the Biologics Industry’s Hottest Technology Available in Your Own FactoryByRussell Miller, EnzeneAugust 19th 2026Sponsored
The Next-Generation Analytical ToolkitByColette Quinn, Waters Corporation,Deanna Hunt, KBI Biopharma,Lance Cadang, Genentech,Zhengqi Zhang, Merck & CoAugust 5th 2026Sponsored
FDA’s 2026 Draft Guidance on Nonclinical Safety for Antibody Drug ConjugatesByColette Quinn, Waters Corporation,Deanna Hunt, KBI Biopharma,Lance Cadang, Genentech,Zhengqi Zhang, Merck & CoAugust 5th 2026Sponsored
The Transition from Manufacturing to GMPByColette Quinn, Waters Corporation,Deanna Hunt, KBI Biopharma,Lance Cadang, Genentech,Zhengqi Zhang, Merck & CoAugust 5th 2026Sponsored
